Viking enrolls around 280 participants in the phase II study evaluating the oral version of its obesity drug. Data from this ...

Post this buyout, it added a differentiated portfolio of incretins to its pipeline, which includes CT-388, CT-996 and CT-868. A dual GLP-1/GIP receptor agonist, CT-388, is being evaluated in a mid ...

People pick weak passwords or reuse them over devices, tokens are lost, compromised or bypassed, and biometrics can be forced ...

RG6652 (CT-966) and RG6640 (CT-388) are in phase 1 and phase 2 testing, respectively, for obesity with and without T2D, while RG6641 (CT-868) is in phase 2 as an adjunct to insulin in overweight ...

The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 – also sourced from Carmot – achieved an average weight loss of 18.8% at 24 weeks in a phase 1b trial ...

Why is Elon Musk, the richest man in the world, hyperventilating about Social Security? Why is he inventing unhinged tales ...

President Donald Trump is downplaying the texting of attack plans to a group chat that included a journalist as “the only ...